1. 320. PEDIATRIC OPEN-LABEL CLINICAL STUDY OF RITUXIMAB FOR THE TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS AND MICROSCOPIC POLYANGIITIS. (29th March 2019) Authors: Brogan, Paul; Cleary, Gavin; Hersh, Aimee; Kasapcopur, Ozgur; Rangaraj, Satyapal; Yeung, Rae; Zeft, Andrew; Kirchner, Petra; Brunetta, Paul; Cooper, Jennifer; Pordeli, Pooneh; Lehane, Patricia Journal: Rheumatology Issue: Volume 58(2019)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 327. LONG-TERM SAFETY OF RITUXIMAB IN GRANULOMATOSIS WITH POLYANGIITIS OR MICROSCOPIC POLYANGIITIS: RESULTS OF THE FOUR-YEAR RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS REGISTRY. (29th March 2019) Authors: Niles, John; Merkel, Peter; Mertz, Lester; Lehane, Patricia; Pordeli, Pooneh; Erblang, Felix Journal: Rheumatology Issue: Volume 58(2019)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗